This is the authors' abstract. We don't add key points for this paper.
// Zheng-Shi Wang 1, * , Ming Zhong 1, * , Yu-Hai Bian 1 , Yi-Fei Mu 1 , Shao-Lan Qin 1 , Min-Hao Yu 1 , Jun Qin 1 1 Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China * These authors have contributed equally to this work Correspondence to: Jun Qin, email: dr.qinjun@gmail.com Min-Hao Yu, email: fishmeangood@163.com Keywords: microRNA-187, CD276, colorectal cancer, growth, invasion Received: October 14, 2015 Accepted: May 11, 2016 Published: June 14, 2016 ABSTRACT Aberrantly expressed microRNAs contribute to the initiation and progression of human cancers. However, the underlying functions of microRNA-187 (miR-187) in colorectal cancer (CRC) remain largely unexplored. Here, we demonstrated that miR-187 was significantly down-regulated in CRC tissues and cell lines compared to their normal counterparts. By Kaplan-Meier analysis, we revealed that decreased miR-187 expression was closely associated with shorter overall survival and relapse-free survival of patients with CRC. By gain- and loss-of-function studies, we showed that miR-187 remarkably suppressed CRC cell proliferation, migration, invasion, and promoted cell apoptosis. Furthermore, bioinformatics analysis and luciferase reporter assay identified that CD276 was the direct functional target of miR-187 in CRC. Genetic silencing of CD276 recapitulated similar phenotype as observed in over-expression of miR-187, and restoration of CD276 completely rescued the inhibitory effect of miR-187 in CRC cells. Taken together, our study implied the essential roles of miR-187 in suppressing CRC progression, and a novel link between miR-187 and CD276 in CRC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: